fda approved oral semaglutide Gets Approval for CV Event Reduction in High-risk Diabetes Patients FDA Approves Oral Semaglutide: First

Eating food 2-3 hours before bed may help reduce this

Heres to a healthier, more active future

Studies of efinopegdutide, another dual GLP-1/GCGR agonist, have shown preliminary efficacy

163 Consumption of an HSD promotes an increase in the abundance of Bifidobacterium , which, due to enhanced gut permeability, infiltrates tumors, subsequently augmenting the functionality of NK cells and ultimately contributing to tumor regression

Early results suggest retatrutide could offer even better metabolic benefits that tirzepatide, though direct comparison trials are needed

Body Composition Research: Investigators study how elevated GH and IGF-1 signaling influence lean mass and fat metabolism in animal models